These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31705538)

  • 1. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.
    Kirby JS; Thorlacius L; Villumsen B; Ingram JR; Garg A; Christensen KB; Butt M; Esmann S; Tan J; Jemec GBE
    Br J Dermatol; 2020 Aug; 183(2):340-348. PubMed ID: 31705538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
    Kirby JS; Hereford B; Thorlacius L; Villumsen B; Ingram JR; Garg A; Butt M; Esmann S; King T; Tan J; Jemec GBE
    Br J Dermatol; 2021 Apr; 184(4):681-687. PubMed ID: 32602129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent Validity of Suffering and Quality of Life as Measured by The Hidradenitis Suppurativa Quality of Life.
    Kursawe Larsen C; Kjaersgaard Andersen R; Kirby JS; Tan J; Saunte DML; Jemec GBE
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1577-1581. PubMed ID: 33539563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
    Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
    Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Real-World Application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Score to Adults with Hidradenitis Suppurativa.
    Garg A; Burge R; Cohee A; Wallinger H; Truman I; Keal A; Strunk A; Barlow S
    Br J Dermatol; 2024 Oct; ():. PubMed ID: 39374841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
    Kirby JS; Butt M; King T
    Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.
    Thorlacius L; Esmann S; Miller I; Vinding G; Jemec GBE
    Skin Appendage Disord; 2019 Jun; 5(4):221-229. PubMed ID: 31367600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.
    Sisic M; Kirby JS; Boyal S; Plant L; McLellan C; Tan J
    J Cutan Med Surg; 2017; 21(2):152-155. PubMed ID: 27837158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.
    Kimball AB; Sundaram M; Banderas B; Foley C; Shields AL
    J Dermatolog Treat; 2018 Mar; 29(2):152-164. PubMed ID: 28608738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
    Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
    JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Resilience With Depression and Health-Related Quality of Life for Patients With Hidradenitis Suppurativa.
    Kirby JS; Butt M; Esmann S; Jemec GBE
    JAMA Dermatol; 2017 Dec; 153(12):1263-1269. PubMed ID: 29117300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa.
    McLellan C; Sisic M; Oon HH; Tan J
    J Cutan Med Surg; 2018; 22(2):142-146. PubMed ID: 28992738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-life evaluation in hidradenitis suppurativa in Australia: Validation and outcomes of the HiSQOL questionnaire.
    Wu K; Larney C; Marshman G; Spelman L; Rubel D; Mcmeniman E; Veysey E; Saunders H; Frew JW
    Australas J Dermatol; 2024 Dec; 65(8):630-635. PubMed ID: 39387265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life in Hidradenitis Suppurativa: An Update.
    Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Sampogna F; Marron SE; Zemskov SV; Abeni D; Tzellos T; Szepietowski JC; Zouboulis CC
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34204126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatments and new assessment instruments for Hidradenitis suppurativa.
    van Straalen KR; Ingram JR; Augustin M; Zouboulis CC
    Exp Dermatol; 2022 Sep; 31 Suppl 1(Suppl 1):33-39. PubMed ID: 35582833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa.
    Marrón SE; Gómez-Barrera M; Tomás-Aragonés L; Díaz Díaz RM; Vilarrasa Rull E; Madrid Álvarez MB; Puig L
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):554-560. PubMed ID: 31023484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.
    Peris K; Lo Schiavo A; Fabbrocini G; Dini V; Patrizi A; Fusano M; Bianchi L; Guanziroli E; Guarneri C; Parodi A; Bertoldi A; Musumeci ML; Offidani A; Rongioletti F; Pistone G; Malara G; Potenza C; Casari A; Franchi C; Ardigò M; Cusano F; Stingeni L; Amerio P; Mancini LL; Prignano F; Deboli T; Gualberti G; Saragaglia V; Bettoli V
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):766-773. PubMed ID: 30633405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.